MXPA05014203A - Procedimientos para la preparacion de derivados de benzoimidazol. - Google Patents
Procedimientos para la preparacion de derivados de benzoimidazol.Info
- Publication number
- MXPA05014203A MXPA05014203A MXPA05014203A MXPA05014203A MXPA05014203A MX PA05014203 A MXPA05014203 A MX PA05014203A MX PA05014203 A MXPA05014203 A MX PA05014203A MX PA05014203 A MXPA05014203 A MX PA05014203A MX PA05014203 A MXPA05014203 A MX PA05014203A
- Authority
- MX
- Mexico
- Prior art keywords
- benzoimidazole
- quinolin
- piperidin
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Abstract
La presente invencion se refiere a un procedimiento para preparar un compuesto de formula l (ver formula (I)) o una sal, profarmaco, hidrato o solvato farmaceuticamente aceptable del mismo en el que R1, R2, R3 y R4 son como se definen en el presente documento; el compuesto de formula I es util en el tratamiento del crecimiento celular anormal, tal como cancer, en mamiferos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48217603P | 2003-06-24 | 2003-06-24 | |
| PCT/IB2004/001983 WO2004113322A1 (en) | 2003-06-24 | 2004-06-14 | Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05014203A true MXPA05014203A (es) | 2006-02-24 |
Family
ID=33539339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05014203A MXPA05014203A (es) | 2003-06-24 | 2004-06-14 | Procedimientos para la preparacion de derivados de benzoimidazol. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7183414B2 (es) |
| EP (1) | EP1641780B1 (es) |
| JP (1) | JP2007516168A (es) |
| KR (2) | KR20070092333A (es) |
| CN (1) | CN100404530C (es) |
| AR (1) | AR044849A1 (es) |
| AT (1) | ATE414077T1 (es) |
| AU (1) | AU2004249511B2 (es) |
| BR (1) | BRPI0411794A (es) |
| CA (1) | CA2529032C (es) |
| CL (1) | CL2004001470A1 (es) |
| CO (1) | CO5650165A2 (es) |
| DE (1) | DE602004017731D1 (es) |
| DK (1) | DK1641780T3 (es) |
| ES (1) | ES2315663T3 (es) |
| HK (1) | HK1089170A1 (es) |
| IL (1) | IL172064A (es) |
| MX (1) | MXPA05014203A (es) |
| NO (1) | NO20060376L (es) |
| NZ (2) | NZ543714A (es) |
| RU (1) | RU2323214C2 (es) |
| SG (1) | SG161745A1 (es) |
| TW (1) | TWI294425B (es) |
| WO (1) | WO2004113322A1 (es) |
| ZA (1) | ZA200509253B (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
| JP2008515872A (ja) * | 2004-10-07 | 2008-05-15 | ファイザー・プロダクツ・インク | 抗増殖剤として有用なベンゾイミダゾール誘導体 |
| KR20080013886A (ko) * | 2005-04-05 | 2008-02-13 | 파마코페이아, 인코포레이티드 | 면역억제용 퓨린 및 이미다조피리딘 유도체 |
| US7504513B2 (en) | 2006-02-27 | 2009-03-17 | Hoffman-La Roche Inc. | Thiazolyl-benzimidazoles |
| WO2010016005A1 (en) | 2008-08-06 | 2010-02-11 | Pfizer Inc. | 6 substituted 2-heterocyclylamino pyrazine compounds as chk-1 inhibitors |
| CA2745596A1 (en) | 2008-12-18 | 2010-10-28 | F. Hoffmann-La Roche Ag | Thiazolyl-benzimidazoles |
| CN101993416B (zh) * | 2009-08-27 | 2013-09-11 | 中国科学院上海药物研究所 | 喹啉类化合物、其制备方法、包含该化合物的药物组合物及该化合物的用途 |
| JP6407504B2 (ja) | 2012-09-21 | 2018-10-17 | アログ・ファーマシューティカルズ・インコーポレイテッドＡｒｏｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 恒常的に活性であるリン酸化型ｆｌｔ３キナーゼの阻害方法 |
| JP6042157B2 (ja) | 2012-09-26 | 2016-12-14 | アログ・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニーＡｒｏｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，ＬＬＣ | 変異型ｃ−ｋｉｔの阻害方法 |
| US11642340B2 (en) | 2012-09-26 | 2023-05-09 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
| US10835525B2 (en) | 2012-09-26 | 2020-11-17 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
| BR112015016282A2 (pt) | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
| US10463658B2 (en) | 2013-10-25 | 2019-11-05 | Videra Pharmaceuticals, Llc | Method of inhibiting FLT3 kinase |
| EA201991078A1 (ru) | 2016-11-02 | 2019-11-29 | Креноланиб для лечения пролиферативных расстройств, связанных с мутацией flt3 | |
| CN107382983B (zh) * | 2017-08-24 | 2020-08-07 | 扬州市三药制药有限公司 | 一种治疗白血病药物的合成方法 |
| CN107382984B (zh) * | 2017-08-24 | 2020-07-10 | 扬州市三药制药有限公司 | 一种治疗白血病药物的制备方法 |
| CN110840893A (zh) | 2018-12-13 | 2020-02-28 | 安罗格制药有限责任公司 | 含克莱拉尼的药物组合物及其用途 |
| CN109678849A (zh) * | 2019-01-16 | 2019-04-26 | 北京悦康科创医药科技股份有限公司 | 一种抗癌药物的制备方法 |
| US11471451B2 (en) | 2019-08-19 | 2022-10-18 | Arog Pharmaceuticals, Inc. | Uses of crenolanib |
| CN114702428B (zh) * | 2019-12-09 | 2023-11-28 | 苏州恩华生物医药科技有限公司 | 连双环结构sigma-1受体抑制剂 |
| WO2022019998A1 (en) * | 2020-07-20 | 2022-01-27 | Arog Pharmaceuticals, Inc. | Crystal forms of crenolanib and methods of use thereof |
| US20220079934A1 (en) * | 2020-09-17 | 2022-03-17 | Arog Pharmaceuticals, Inc. | Crenolanib for treating pain |
| US11524006B2 (en) | 2020-09-17 | 2022-12-13 | Arog Pharmaceuticals, Inc. | Crenolanib for treating TRK kinase associated proliferative disorders |
| US11969420B2 (en) | 2020-10-30 | 2024-04-30 | Arog Pharmaceuticals, Inc. | Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders |
| CN113683594B (zh) * | 2021-09-07 | 2022-12-27 | 曲靖师范学院 | 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用 |
| JP2023063189A (ja) | 2021-10-22 | 2023-05-09 | アログ・ファーマシューティカルズ・インコーポレイテッド | 以前の治療に対して再発性／不応性のｆｌｔ３突然変異増殖性障害を治療するためのクレノラニブ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69839305T2 (de) * | 1997-02-27 | 2009-04-09 | Takeda Pharmaceutical Co. Ltd. | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta |
| UA75055C2 (uk) * | 1999-11-30 | 2006-03-15 | Пфайзер Продактс Інк. | Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі |
| EP1245390A4 (en) * | 1999-12-10 | 2009-04-01 | Fujifilm Corp | INK JET HEAD AND PRINTER |
| EP1321454A4 (en) * | 2000-09-14 | 2005-11-02 | Kaneka Corp | PROCESS FOR EXTRACTING NITROBENZENESULFONYL |
| PA8580301A1 (es) * | 2002-08-28 | 2005-05-24 | Pfizer Prod Inc | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos |
-
2004
- 2004-06-14 NZ NZ543714A patent/NZ543714A/en not_active IP Right Cessation
- 2004-06-14 RU RU2005138367/04A patent/RU2323214C2/ru active
- 2004-06-14 DE DE602004017731T patent/DE602004017731D1/de active Active
- 2004-06-14 CL CL200401470A patent/CL2004001470A1/es unknown
- 2004-06-14 ES ES04736779T patent/ES2315663T3/es active Active
- 2004-06-14 KR KR1020077019713A patent/KR20070092333A/ko not_active Application Discontinuation
- 2004-06-14 KR KR1020057024593A patent/KR100787649B1/ko active IP Right Grant
- 2004-06-14 CN CNB2004800175706A patent/CN100404530C/zh active Active
- 2004-06-14 SG SG200700254-6A patent/SG161745A1/en unknown
- 2004-06-14 EP EP04736779A patent/EP1641780B1/en active Active
- 2004-06-14 MX MXPA05014203A patent/MXPA05014203A/es active IP Right Grant
- 2004-06-14 JP JP2006516552A patent/JP2007516168A/ja active Pending
- 2004-06-14 DK DK04736779T patent/DK1641780T3/da active
- 2004-06-14 AU AU2004249511A patent/AU2004249511B2/en not_active Ceased
- 2004-06-14 WO PCT/IB2004/001983 patent/WO2004113322A1/en active Application Filing
- 2004-06-14 CA CA002529032A patent/CA2529032C/en active Active
- 2004-06-14 AT AT04736779T patent/ATE414077T1/de not_active IP Right Cessation
- 2004-06-14 BR BRPI0411794-8A patent/BRPI0411794A/pt not_active IP Right Cessation
- 2004-06-14 NZ NZ571898A patent/NZ571898A/en not_active IP Right Cessation
- 2004-06-22 AR ARP040102160A patent/AR044849A1/es unknown
- 2004-06-23 TW TW093118112A patent/TWI294425B/zh not_active IP Right Cessation
- 2004-06-23 US US10/875,030 patent/US7183414B2/en active Active
-
2005
- 2005-11-15 ZA ZA200509253A patent/ZA200509253B/en unknown
- 2005-11-20 IL IL172064A patent/IL172064A/en active IP Right Grant
- 2005-12-20 CO CO05127734A patent/CO5650165A2/es active IP Right Grant
-
2006
- 2006-01-24 NO NO20060376A patent/NO20060376L/no not_active Application Discontinuation
- 2006-08-28 HK HK06109559A patent/HK1089170A1/xx not_active IP Right Cessation
- 2006-12-05 US US11/567,071 patent/US20070088032A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05014203A (es) | Procedimientos para la preparacion de derivados de benzoimidazol. | |
| MXPA06013164A (es) | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. | |
| GEP20084357B (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| TW200640900A (en) | 1-(2h)-isoquinolone derivative | |
| BRPI0511512A (pt) | derivados pirrolpirimidina úteis no tratamento do cáncer | |
| CA2413424A1 (en) | Substituted bicyclic derivatives for the treatment of abnormal cell growth | |
| MXPA03010877A (es) | Derivados de 2-anilin-pirimida como inhibidores de cinasa dependientes de ciclina. | |
| CA2362394A1 (en) | Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents | |
| MEP0908A (xx) | Derivati pirimidina za tretman neprirodnog rasta ćelija | |
| GEP20104875B (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| CA2358998A1 (en) | Substituted bicyclic derivatives useful as anticancer agents | |
| WO2005037825A3 (en) | Protein kinase inhibitors | |
| YU30702A (sh) | Novi derivati benzoimidazola, korisni agensi protiv proliferacije | |
| WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
| LU91761I2 (fr) | Vernakalant et ses dérivés pharmaceutiquement acceptables et en particulier son sel d'hydrochlorure (BRINAVESS®) | |
| CA2290918A1 (en) | Heteroaromatic bicyclic derivatives useful as anticancer agents | |
| WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
| GEP20074045B (en) | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease | |
| JO2413B1 (en) | Benzoxazine derivatives and their use | |
| DE69907419D1 (en) | Antitumorwirkstoffe | |
| WO2006129168A3 (en) | Bicyclic derivatives for the treatment of abnormal cell growth | |
| IL166057A0 (en) | Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments | |
| RS44004A (en) | Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth | |
| WO2004073601A3 (en) | Process for the preparation of hexacyclic camptothecin derivatives | |
| RS20050954A (en) | Use of bycyclo/2.2.1/heptane derivatives for the preparation of neuroprotective pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |